3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
NET
1
Endocrine
1
Conditions
Stomach Neoplasms
15
Colorectal Neoplasms
13
Esophageal Neoplasms
10
Barrett Esophagus
8
Gastrointestinal Neoplasms
6
Colonic Polyps
6
Colonic Neoplasms
6
Rectal Neoplasms
5
Neoplasms
3
Adenoma, Villous
3
Adenocarcinoma Of Esophagus
3
Rectal Neuroendocrine Tumors
2
Precancerous Conditions
2
Hemorrhage
2
Gastric GIST
2
Esophageal Squamous Cell Carcinoma
2
Duodenal Neoplasms
2
Adenoma
2
Tobacco Use Disorder
1
Submucosal Tumor of Stomach
1
Small Size Gastrointestinal Stromal Tumors
1
Small Cell Lung Carcinoma
1
Predictive Cancer Model
1
Polyps
1
Polyposis, Gastric
1
Pituitary Neoplasms
1
Personal Satisfaction
1
Pathological Conditions, Anatomical
1
Paranasal Sinus Neoplasms
1
Pancreatic Neoplasms
1
Interventions
lutetium Lu 177 dotatate
29
Everolimus
19
Temozolomide
11
gallium Ga 68 dotatate
10
Nivolumab
10
Magnetic Resonance Spectroscopy
10
Capecitabine
9
pembrolizumab
8
lanreotide
8
Positron Emission Tomography Computed Tomography
8
cabozantinib
7
3-Iodobenzylguanidine
7
177Lu-octreotide, DOTA(0)-Tyr(3)-
7
Somatostatin
6
90Y-octreotide, DOTA-Tyr(3)-
6
telotristat ethyl
5
lenvatinib
5
Octreotide
5
Lutetium-177
5
Ga(III)-DOTATOC
5
Fluorodeoxyglucose F18
5
Carboplatin
5
avelumab
4
Positron-Emission Tomography
4
Ipilimumab
4
Bevacizumab
4
surufatinib
3
pasireotide
3
fluorodopa F 18
3
copper dotatate CU-64
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Neuroendocrine Tumors
×
Endoscopic Mucosal Resection
×
Clear all
NCT06121752
2024-10-15
DNET
Asian Institute of Gastroenterology, India
Phase NA
Unknown
54 enrolled